Related references
Note: Only part of the references are listed.Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted Drugs
Gregory M. Cresswell et al.
CANCER RESEARCH (2021)
Entinostat plus Pembrolizumab in Patients with Metastatic NSCLC Previously Treated with Anti-PD-(L)1 Therapy
Matthew D. Hellmann et al.
CLINICAL CANCER RESEARCH (2021)
The multifaceted role of TRAIL signaling in cancer and immunity
Ludmila Cardoso Alves et al.
FEBS JOURNAL (2021)
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer A Randomized Clinical Trial
Veronica Mariotti et al.
JAMA ONCOLOGY (2021)
The Functional Crosstalk between Myeloid-Derived Suppressor Cells and Regulatory T Cells within the Immunosuppressive Tumor Microenvironment
Maximilian Haist et al.
CANCERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MDSC: Markers, development, states, and unaddressed complexity
Samarth Hegde et al.
IMMUNITY (2021)
Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
David H. Aggen et al.
CLINICAL CANCER RESEARCH (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Retinoic Acid Synthesis Deficiency Fosters the Generation of Polymorphonuclear Myeloid-Derived Suppressor Cells in Colorectal Cancer
Hong-Wei Sun et al.
CANCER IMMUNOLOGY RESEARCH (2021)
TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis
Dehong Yan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
Naoki Horikawa et al.
BRITISH JOURNAL OF CANCER (2020)
Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
Takaaki Masuda et al.
CANCER SCIENCE (2020)
TIGIT as an emerging immune checkpoint
H. Harjunpaa et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models
Sarah Greene et al.
CLINICAL CANCER RESEARCH (2020)
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Zhihao Lu et al.
NATURE (2020)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A. Flores-Toro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Defining the emergence of myeloid-derived suppressor cells in breast cancer using single-cell transcriptomics
Hamad Alshetaiwi et al.
SCIENCE IMMUNOLOGY (2020)
Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors
Ayumi Hashimoto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Chiara Porta et al.
CANCER RESEARCH (2020)
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection
Erik Wennerberg et al.
CANCER IMMUNOLOGY RESEARCH (2020)
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
Eslam Mohamed et al.
IMMUNITY (2020)
Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
Carole Siret et al.
FRONTIERS IN IMMUNOLOGY (2020)
Myeloid-Derived Suppressor Cell Subsets Drive Glioblastoma Growth in a Sex-Specific Manner
Defne Bayik et al.
CANCER DISCOVERY (2020)
1α, 25 Dihydroxyvitamin D (1,25(OH)2D) inhibits the T cell suppressive function of myeloid derived suppressor cells (MDSC)
J. C. Fleet et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils
Anm Nazmul H. Khan et al.
CANCER IMMUNOLOGY RESEARCH (2020)
Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
Aohan Hou et al.
FRONTIERS IN IMMUNOLOGY (2020)
Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action
Yukinori Take et al.
FRONTIERS IN IMMUNOLOGY (2020)
Heat shock and HSP70 regulate 5-FU-mediated caspase-1 activation in myeloid-derived suppressor cells and tumor growth in mice
Thomas Pilot et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal
Tobias Baumann et al.
NATURE IMMUNOLOGY (2020)
Galectin-9 promotes a suppressive microenvironment in human cancer by enhancing STING degradation
Chuan-xia Zhang et al.
ONCOGENESIS (2020)
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Yuhui Yang et al.
FRONTIERS IN IMMUNOLOGY (2020)
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco et al.
FRONTIERS IN IMMUNOLOGY (2020)
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross- presentation by dendritic cells in cancer
Alessio Ugolini et al.
JCI INSIGHT (2020)
The adenosine pathway in immuno-oncology
Bertrand Allard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
IDO Expression in Cancer: Different Compartment, Different Functionality?
Annabel Meireson et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
Nathan Karin
FRONTIERS IN IMMUNOLOGY (2020)
Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation
Luca Cassetta et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
Guo Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Carmen Salvador-Coloma et al.
EUROPEAN JOURNAL OF CANCER (2020)
Tasquinimod targets suppressive myeloid cells in the tumor microenvironment
Li Shen et al.
ONCOIMMUNOLOGY (2019)
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy
Ryuma Tokunaga et al.
CLINICAL COLORECTAL CANCER (2019)
STAT3 inhibition induces Bax-dependent apoptosis in liver tumor myeloid-derived suppressor cells
Prajna Guha et al.
ONCOGENE (2019)
Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
Alexander J. Muller et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Emerging Principles in Myelopoiesis at Homeostasis and during Infection and Inflammation
Joachim L. Schultze et al.
IMMUNITY (2019)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging
Antero Salminen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Yu Zheng et al.
MOLECULAR CANCER (2019)
Fatty acid transport protein 2 reprograms neutrophils in cancer
Filippo Veglia et al.
NATURE (2019)
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
Shengmeng Di et al.
FRONTIERS IN ONCOLOGY (2019)
Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment
Adelie Dumont et al.
CELL DEATH & DISEASE (2019)
Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9
Yungang Wang et al.
ADVANCED SCIENCE (2019)
AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells
Jimena Trillo-Tinoco et al.
CANCER RESEARCH (2019)
Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs
Charles S. Tannenbaum et al.
CANCER IMMUNOLOGY RESEARCH (2019)
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma
Alisha Holtzhausen et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma
Lei Wu et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
Marijo Bilusic et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
Rosalinda Trovato et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Livingstone Fultang et al.
EBIOMEDICINE (2019)
Combining alpha radiation-based brachytherapy with immunomodulators promotes complete tumor regression in mice via tumor-specific long-term immune response
Vered Domankevich et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells
Hemn Mohammadpour et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Targeting CD39 in Cancer Reveals an Extracellular ATP- and Inflammasome-Driven Tumor Immunity
Xian-Yang Li et al.
CANCER DISCOVERY (2019)
Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
Yu Si et al.
SCIENCE IMMUNOLOGY (2019)
T-cell-Secreted TNFα Induces Emergency Myelopoiesis and Myeloid-Derived Suppressor Cell Differentiation in Cancer
Mohamad F. Al Sayed et al.
CANCER RESEARCH (2019)
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis
Brian W. Labadie et al.
CLINICAL CANCER RESEARCH (2019)
The success and the challenge of all-trans retinoic acid in the treatment of cancer
Xiaoling Ni et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2019)
Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
Peiqi Xu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Newly developed anti-S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis
Rie Kinoshita et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Safety, tolerability, and pharmacology of AB928, a novel dual adenosine receptor antagonist, in a randomized, phase 1 study in healthy volunteers
Lisa Seitz et al.
INVESTIGATIONAL NEW DRUGS (2019)
Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence
Biagio Ricciuti et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment
Alba Gonzalez-Junca et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
Emeric Limagne et al.
ONCOIMMUNOLOGY (2019)
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Yungang Wang et al.
FRONTIERS IN IMMUNOLOGY (2019)
A Phase 2 Study to Assess the Immunomodulatory Capacity of a Lecithin-based Delivery System of Curcumin in Endometrial Cancer
Sandra Tuyaerts et al.
FRONTIERS IN NUTRITION (2019)
MicroRNA networks regulate the differentiation, expansion and suppression function of myeloid-derived suppressor cells in tumor microenvironment
Yanping Su et al.
JOURNAL OF CANCER (2019)
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Lillian Sun et al.
JCI INSIGHT (2019)
Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
David M. Peereboom et al.
JCI INSIGHT (2019)
Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis
Elham Safarzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
Pranabananda Dutta et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery
K-E Andersson
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Developing TRAIL/TRAIL death receptor-based cancer therapies
Xun Yuan et al.
CANCER AND METASTASIS REVIEWS (2018)
Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer
Fangxuan Li et al.
CANCER BIOLOGY & THERAPY (2018)
mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells
Yuting Deng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li et al.
CANCER RESEARCH (2018)
A RIPK3-PGE(2) Circuit Mediates Myeloid-Derived Suppressor Cell-Potentiated Colorectal Carcinogenesis
Guifang Yan et al.
CANCER RESEARCH (2018)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Masoud F. Tavazoie et al.
CELL (2018)
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study
Jurgen Sota et al.
CLINICAL RHEUMATOLOGY (2018)
Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells - is a new era coming?
Karolina Okla et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2018)
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Yong Wang et al.
JOURNAL OF IMMUNOLOGY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Targeting the NLRP3 inflammasome in inflammatory diseases
Matthew S. J. Mangan et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
THE PROKINETICINS: NEUROMODULATORS AND MEDIATORS OF INFLAMMATION AND MYELOID CELL-DEPENDENT ANGIOGENESIS
Lucia Negri et al.
PHYSIOLOGICAL REVIEWS (2018)
BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells
Eva Hajek et al.
Oncotarget (2018)
A novel MDSC-induced PD-1(-)PD-L1(+) B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties
Meng Shen et al.
ONCOIMMUNOLOGY (2018)
VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
Liru Wang et al.
ONCOIMMUNOLOGY (2018)
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
Guohui Qin et al.
ONCOIMMUNOLOGY (2018)
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab
Richard P. Tobin et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers
Dayson Moreira et al.
CLINICAL CANCER RESEARCH (2018)
Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into CheckpointResponsive Tumors by Reprogramming Tumor-Infiltrating MDSCs
Brian J. Christmas et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Reactive Oxygen Species as Regulators of MDSC-Mediated Immune Suppression
Kim Ohl et al.
FRONTIERS IN IMMUNOLOGY (2018)
STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.
Matthew J. Reilley et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
Tyler J. Alban et al.
JCI INSIGHT (2018)
Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice
Zhen Bian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Regulation of myelopoiesis by proinflammatory cytokines in infectious diseases
Yukino Chiba et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid Signals
Gulidanna Shayan et al.
CLINICAL CANCER RESEARCH (2018)
CCR5(+) Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions
Carolin Blattner et al.
CANCER RESEARCH (2018)
Blockage of the NLRP3 inflammasome by MCC950 improves anti-tumor immune responses in head and neck squamous cell carcinoma
Lei Chen et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
George A. Dominguez et al.
CLINICAL CANCER RESEARCH (2017)
Phase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN
Laura Q. M. Chow et al.
CLINICAL CANCER RESEARCH (2017)
Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
Naoki Horikawa et al.
CLINICAL CANCER RESEARCH (2017)
Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis
Z. Deng et al.
ONCOGENE (2017)
On the origin of myeloid-derived suppressor cells
Camilla Rydberg Millrud et al.
ONCOTARGET (2017)
The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets
Bertrand Allard et al.
IMMUNOLOGICAL REVIEWS (2017)
Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression
Huifang Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Novel therapeutic approach to improve hematopoiesis in low risk MDS by targeting MDSCs with the Fc-engineered CD33 antibody BI 836858
E. A. Eksioglu et al.
LEUKEMIA (2017)
The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2
Torsten Hartwig et al.
MOLECULAR CELL (2017)
COX2/mPGES1/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells
Victor Prima et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers
Bernard Escudier et al.
TARGETED ONCOLOGY (2017)
Bisdemethoxycurcumin in combination with α-PD-L1 antibody boosts immune response against bladder cancer
Yiqun Shao et al.
ONCOTARGETS AND THERAPY (2017)
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
Shiou-Ling Jian et al.
CELL DEATH & DISEASE (2017)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang et al.
NATURE COMMUNICATIONS (2017)
Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade
Maria Ouzounova et al.
NATURE COMMUNICATIONS (2017)
Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells
Javier Rodriguez-Ubreva et al.
CELL REPORTS (2017)
Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells
Zibing Wang et al.
ONCOIMMUNOLOGY (2017)
EP4 Antagonism by E7046 diminishes Myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity
Diana I. Albu et al.
ONCOIMMUNOLOGY (2017)
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF--mTOR-HIF-1 signaling in patients with non-small cell lung cancer
Jieyao Li et al.
ONCOIMMUNOLOGY (2017)
Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe)
Jessica C. Hassel et al.
ONCOIMMUNOLOGY (2017)
Exogenous lipid uptake induces metabolic and functional reprogramming of tumor-associated myeloid-derived suppressor cells
Amir A. Al-Khami et al.
ONCOIMMUNOLOGY (2017)
Targeting immunosuppressive adenosine in cancer
D. Vijayan et al.
NATURE REVIEWS CANCER (2017)
Interleukin-8 in cancer pathogenesis, treatment and follow-up
Carlos Alfaro et al.
CANCER TREATMENT REVIEWS (2017)
Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2-Negative Metastatic Breast Cancer
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2017)
Entinostat Neutralizes Myeloid-Derived Suppressor Cells and Enhances the Antitumor Effect of PD-1 Inhibition in Murine Models of Lung and Renal Cell Carcinoma
Ashley Orillion et al.
CLINICAL CANCER RESEARCH (2017)
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M. F. Sanmamed et al.
ANNALS OF ONCOLOGY (2017)
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer
Dingzhi Wang et al.
CANCER RESEARCH (2017)
Myeloid Cells That Impair Immunotherapy Are Restored in Melanomas with Acquired Resistance to BRAF Inhibitors
Shannon M. Steinberg et al.
CANCER RESEARCH (2017)
Oncolytic Virus-Mediated Targeting of PGE2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
Weizhou Hou et al.
CANCER CELL (2016)
CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma
Colin W. Steele et al.
CANCER CELL (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Accumulation of MDSC and Th17 Cells in Patients with Metastatic Colorectal Cancer Predicts the Efficacy of a FOLFOX-Bevacizumab Drug Treatment Regimen
Emeric Limagne et al.
CANCER RESEARCH (2016)
Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling
Dongjun Peng et al.
CANCER RESEARCH (2016)
Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26
David Kung-Chun Chiu et al.
HEPATOLOGY (2016)
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar et al.
IMMUNITY (2016)
Curdlan blocks the immune suppression by myeloid-derived suppressor cells and reduces tumor burden
Ke Rui et al.
IMMUNOLOGIC RESEARCH (2016)
Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil
Junpu Wang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer
Cora Sternberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2
Daniel W. Beury et al.
JOURNAL OF IMMUNOLOGY (2016)
Yeast-Derived Particulate β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer
Sabrin H. Albeituni et al.
JOURNAL OF IMMUNOLOGY (2016)
Effect of First-Line Treatment on Myeloid-Derived Suppressor Cells' Subpopulations in the Peripheral Blood of Patients with Non-Small Cell Lung Cancer
Filippos Koinis et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
Emma Eriksson et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial
Timothy M. Nywening et al.
LANCET ONCOLOGY (2016)
Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
Katrin Moses et al.
SEMINARS IN IMMUNOLOGY (2016)
Neutrophils in the Tumor Microenvironment
Davalyn R. Powell et al.
TRENDS IN IMMUNOLOGY (2016)
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Vinit Kumar et al.
TRENDS IN IMMUNOLOGY (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells
Asaf Spiegel et al.
CANCER DISCOVERY (2016)
Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin
Junmin Zhou et al.
SCIENTIFIC REPORTS (2016)
Doxorubicin resistant cancer cells activate myeloid-derived suppressor cells by releasing PGE2
Yuan Rong et al.
SCIENTIFIC REPORTS (2016)
G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
Wenbin Li et al.
PROTEIN & CELL (2016)
Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes
Amy W. Ku et al.
ELIFE (2016)
Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
Amir A. Al-Khami et al.
ONCOIMMUNOLOGY (2016)
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
Tingting Wu et al.
SCIENTIFIC REPORTS (2016)
Targeting inflammasome/IL-1 pathways for cancer immunotherapy
Beichu Guo et al.
SCIENTIFIC REPORTS (2016)
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
Thomas Condamine et al.
SCIENCE IMMUNOLOGY (2016)
Poly (I: C) modulates the immunosuppressive activity of myeloid-derived suppressor cells in a murine model of breast cancer
Parvin Forghani et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
RORC1 Regulates Tumor-Promoting Emergency Granulo-Monocytopoiesis
Laura Strauss et al.
CANCER CELL (2015)
Chemotherapy-Derived Inflammatory Responses Accelerate the Formation of Immunosuppressive Myeloid Cells in the Tissue Microenvironment of Human Pancreatic Cancer
Shintaro Takeuchi et al.
CANCER RESEARCH (2015)
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Joseph A. Califano et al.
CLINICAL CANCER RESEARCH (2015)
TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
Dewan M. S. Hossain et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid-Derived Suppressor Cells as an Immune Parameter in Patients with Concurrent Sunitinib and Stereotactic Body Radiotherapy
Hui-Ming Chen et al.
CLINICAL CANCER RESEARCH (2015)
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
Douglas Marvel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
Stefano Ugel et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Expression of Cationic Amino Acid Transporter 2 Is Required for Myeloid-Derived Suppressor Cell-Mediated Control of T Cell Immunity
Cansu Cimen Bozkus et al.
JOURNAL OF IMMUNOLOGY (2015)
Transcriptional regulation of myeloid-derived suppressor cells
Thomas Condamine et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes
Baisakhi Raychaudhuri et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Intertwined regulation of angiogenesis and immunity by myeloid cells
Lee B. Rivera et al.
TRENDS IN IMMUNOLOGY (2015)
Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
Jitka Y. Sagiv et al.
CELL REPORTS (2015)
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Rikke B. Holmgaard et al.
CELL REPORTS (2015)
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Fokhrul Hossain et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset
Gurcan Gunaydin et al.
ONCOIMMUNOLOGY (2015)
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication
Oana Draghiciu et al.
ONCOIMMUNOLOGY (2015)
Particulate β-glucan regulates the immunosuppression of granulocytic myeloid-derived suppressor cells by inhibiting NFIA expression
Xinyu Tian et al.
ONCOIMMUNOLOGY (2015)
Patients with pancreatic adenocarcinoma exhibit elevated levels of myeloid-derived suppressor cells upon progression of disease
Joseph Markowitz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Donald T. Weed et al.
CLINICAL CANCER RESEARCH (2015)
Elevated chronic inflammatory factors and myeloid-derived suppressor cells indicate poor prognosis in advanced melanoma patients
Huanhuan Jiang et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients
Caroline Bergenfelz et al.
PLOS ONE (2015)
Extensive Profiling of the Expression of the Indoleamine 2,3-Dioxygenase 1 Protein in Normal and Tumoral Human Tissues
Ivan Theate et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Resiquimod, a TLR7/8 agonist, promotes differentiation of myeloid-derived suppressor cells into macrophages and dendritic cells
Moonkyu Lee et al.
ARCHIVES OF PHARMACAL RESEARCH (2014)
Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy
M. Tazzari et al.
BRITISH JOURNAL OF CANCER (2014)
Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs Synergistic effects of doxorubicin and vincristine
John Wong et al.
CANCER BIOLOGY & THERAPY (2014)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
Extracellular adenosine metabolism in immune cells in melanoma
Viktor Umansky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells
Akemi Kosaka et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer
George C. Prendergast et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Myeloid Lineage-Specific Deletion of Antioxidant System Enhances Tumor Metastasis
Keiichiro Hiramoto et al.
CANCER PREVENTION RESEARCH (2014)
CCL2/CCR2-Dependent Recruitment of Functional AntigenPresenting Cells into Tumors upon Chemotherapy
Yuting Ma et al.
CANCER RESEARCH (2014)
VISTA Regulates the Development of Protective Antitumor Immunity
Isabelle Le Mercier et al.
CANCER RESEARCH (2014)
HMGB1 Enhances Immune Suppression by Facilitating the Differentiation and Suppressive Activity of Myeloid-Derived Suppressor Cells
Katherine H. Parker et al.
CANCER RESEARCH (2014)
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
Yu Zhu et al.
CANCER RESEARCH (2014)
Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
Yumeng Mao et al.
CLINICAL CANCER RESEARCH (2014)
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
Jessica M. Haverkamp et al.
IMMUNITY (2014)
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
Paul T. Thevenot et al.
IMMUNITY (2014)
Intratumoral COX-2 inhibition enhances GM- CSF immunotherapy against established mouse GL261 brain tumors
Sofia Eberstal et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Enhanced suppressive capacity of tumor-infiltrating myeloid-derived suppressor cells compared with their peripheral counterparts
Sarah K. Maenhout et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
PD-L1 is a novel direct target of HIF-1α., and its blockade under hypoxia enhanced MDSC-mediated T cell activation
Muhammad Zaeem Noman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Myeloid-Derived Suppressor Cells Confer Tumor-Suppressive Functions on Natural Killer Cells via Polyinosinic:Polycytidylic Acid Treatment in Mouse Tumor Models
Hiroaki Shime et al.
JOURNAL OF INNATE IMMUNITY (2014)
Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
Laura Bonapace et al.
NATURE (2014)
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Hong Qin et al.
NATURE MEDICINE (2014)
Liver X receptors in lipid metabolism: opportunities for drug discovery
Cynthia Hong et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Myeloid-Derived Suppressor Cells in the Development of Lung Cancer
Myrna L. Ortiz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
Kimberly A. Noonan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Chemotherapy-induced myeloid suppressor cells and antitumor immunity: The Janus face of chemotherapy in immunomodulation
Zhi-Chun Ding et al.
ONCOIMMUNOLOGY (2014)
A pilot study of autologous tumor lysate-loaded dendritic cell vaccination combined with sunitinib for metastatic renal cell carcinoma
Hirokazu Matsushita et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer
Hua Zhang et al.
BLOOD (2013)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
Janesh Pillay et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration- Resistant Prostate Cancer
A. J. Armstrong et al.
CLINICAL CANCER RESEARCH (2013)
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events
Elio Schouppe et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
Tracy X. Cui et al.
IMMUNITY (2013)
Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer
Kenneth J. Pienta et al.
INVESTIGATIONAL NEW DRUGS (2013)
Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer
Xiaolin Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Jeremy D. Waight et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu et al.
JOURNAL OF IMMUNOLOGY (2013)
Targeting CXCR2 Enhances Chemotherapeutic Response, Inhibits Mammary Tumor Growth, Angiogenesis, and Lung Metastasis
Bhawna Sharma et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Stephanie M. Pyonteck et al.
NATURE MEDICINE (2013)
Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production
Yago Pico de Coana et al.
CANCER IMMUNOLOGY RESEARCH (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer
A. J. Montero et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Cucurbitacin B Regulates Immature Myeloid Cell Differentiation and Enhances Antitumor Immunity in Patients with Lung Cancer
Ping Lu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
I. Poschke et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
Shui Ping Tu et al.
CANCER PREVENTION RESEARCH (2012)
The glutathione disulfide mimetic NOV-002 inhibits cyclophosphamide-induced hematopoietic and immune suppression by reducing oxidative stress
C. Marcela Diaz-Montero et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking
Ibrahim H. Younos et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
TNF signaling drives myeloid-derived suppressor cell accumulation
Xueqiang Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Differential Immunologic and MicroRNA Effects of 2 Dosing Regimens of Recombinant Human Granulocyte/Macrophage Colony Stimulating Factor
Pierre L. Triozzi et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Nitric Oxide-Producing Myeloid-Derived Suppressor Cells Inhibit Vascular E-Selectin Expression in Human Squamous Cell Carcinomas
Ahmed E. Gehad et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
Origins of tumor-associated macrophages and neutrophils
Virna Cortez-Retamozo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression
Suzanne Ostrand-Rosenberg et al.
SEMINARS IN CANCER BIOLOGY (2012)
Effect of CpG ODN on monocytic myeloid derived suppressor cells
Hidekazu Shirota et al.
ONCOIMMUNOLOGY (2012)
Coordinated regulation of myeloid cells by tumours
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL
Pratima Sinha et al.
BLOOD (2011)
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells
Samantha Solito et al.
BLOOD (2011)
Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13
Rachel F. Gabitass et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
PGE2-Induced CXCL12 Production and CXCR4 Expression Controls the Accumulation of Human MDSCs in Ovarian Cancer Environment
Natasa Obermajer et al.
CANCER RESEARCH (2011)
COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
Mitsugu Fujita et al.
CANCER RESEARCH (2011)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
Cellular Redox Pathways as a Therapeutic Target in the Treatment of Cancer
Alberto J. Montero et al.
DRUGS (2011)
In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site
Jessica M. Haverkamp et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Tumor- and organ-dependent infiltration by myeloid-derived suppressor cells
Ibrahim Younos et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions
Junmin Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy
James Finke et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Phase II Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
Roberto Pili et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Barbara Molon et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Sergey Ryzhov et al.
JOURNAL OF IMMUNOLOGY (2011)
Proteomic Pathway Analysis Reveals Inflammation Increases Myeloid-Derived Suppressor Cell Resistance to Apoptosis
Olesya Chornoguz et al.
MOLECULAR & CELLULAR PROTEOMICS (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
Emerging Tim-3 functions in antimicrobial and tumor immunity
Kaori Sakuishi et al.
TRENDS IN IMMUNOLOGY (2011)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy
Saul J. Priceman et al.
BLOOD (2010)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Minu K. Srivastava et al.
CANCER RESEARCH (2010)
Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained
Jennifer S. Ko et al.
CANCER RESEARCH (2010)
Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung
Hironori Satoh et al.
CARCINOGENESIS (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
Luigi Dolcetti et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
Je-In Youn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Use of α,25-Dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma
Jarrett E. Walsh et al.
HUMAN IMMUNOLOGY (2010)
Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer
Oscar Arrieta et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
Cesar A. Corzo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: N1 versus N2 TAN
Zvi G. Fridlender et al.
CANCER CELL (2009)
Arginase I-Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
Paulo C. Rodriguez et al.
CANCER RESEARCH (2009)
Sunitinib Mediates Reversal of Myeloid-Derived Suppressor Cell Accumulation in Renal Cell Carcinoma Patients
Jennifer S. Ko et al.
CLINICAL CANCER RESEARCH (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Cancer-Expanded Myeloid-Derived Suppressor Cells Induce Anergy of NK Cells through Membrane-Bound TGF-beta 1
Hequan Li et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Erica M. Hanson et al.
JOURNAL OF IMMUNOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
1α,25-Dihydroxyvitamin D3 to skew intratumoral levels of immune inhibitory CD34+ progenitor cells into dendritic cells
Jonathan S. Kulbersh et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Chemokine-mediated rapid turnover of myeloid-derived suppressor cells in tumor-bearing mice
Yasushi Sawanobori et al.
BLOOD (2008)
Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice
Maciej Kujawski et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
NOV-002 plus carboplatin in platinum-resistant ovarian cancer
C. N. Krasner et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
The role of myeloid cells in the promotion of tumour angiogenesis
Craig Murdoch et al.
NATURE REVIEWS CANCER (2008)
Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function
Ping-Ying Pan et al.
BLOOD (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj et al.
NATURE MEDICINE (2007)
The terminology issue for myeloid-derived suppressor cells
Dmitry I. Gabrilovich et al.
CANCER RESEARCH (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients
Noweeda Mirza et al.
CANCER RESEARCH (2006)
Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell carcinomas in vivo
Claudia M. Gutschalk et al.
CANCER RESEARCH (2006)
Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the Janus-activated kinase 2/signal transducers and activators of transcription 3 pathway
Y Nefedova et al.
CANCER RESEARCH (2005)
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination
C De Santo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3
DMR Lathers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells
P Serafini et al.
CANCER RESEARCH (2004)
L-arginine modulates CD3ξ expression and T cell function in activated human T lymphocytes
AH Zea et al.
CELLULAR IMMUNOLOGY (2004)
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Y Nefedova et al.
JOURNAL OF IMMUNOLOGY (2004)
Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic study
S Fiorucci et al.
GASTROENTEROLOGY (2003)
Phosphodiesterase 5 inhibitors: Current status and potential applications
DP Rotella
NATURE REVIEWS DRUG DISCOVERY (2002)
Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism
A Mazzoni et al.
JOURNAL OF IMMUNOLOGY (2002)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Gr-1+ myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation
SA Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
